Jupiter Life Line Hospitals Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a consolidated net profit of Rs 50.27 cr for Q4FY26, an increase of 11.5% year-on-year from Rs 45.28 cr in the previous year. For the full year FY26, the consolidated net profit stood at Rs 194.19 cr, compared to Rs 193.75 cr in FY25. Total income for the year rose to Rs 1,542.16 cr from Rs 1,330.75 cr in the previous year.

Board Decisions

The Board of Directors, in its meeting held on May 15, 2026, approved several key proposals. The board declared an interim dividend of Rs 1 per equity share of Rs 10 each for FY26. The record date for determining eligibility is May 22, 2026, and the dividend will be paid on or before June 13, 2026.

Additionally, the board approved the sub-division of each existing equity share of face value Rs 10 into five equity shares of face value Rs 2 each. This move aims to enhance liquidity and make shares more affordable. The alteration of the capital clause of the Memorandum of Association was also approved to give effect to this split.

Financial Performance

The company delivered steady growth across key operational metrics. Consolidated revenue from operations for Q4FY26 increased by 15.1% to Rs 387.84 cr, while full-year revenue grew by 15.3% to Rs 1,435.60 cr. EBITDA for the quarter stood at Rs 89.20 cr, with an EBITDA margin of 23.0%. For the full year, EBITDA was Rs 343.30 cr, with a margin of 22.9%.

Operational Highlights

FY26 operating metrics reflected the company's expansion efforts. Total operational beds increased to 1,248 from 1,061 in the previous year. The average occupancy rate was 61.2% (62.3% excluding the ramp-up Dombivli hospital). Patient volumes grew, with total volume reaching 1,076.4 thousand compared to 979.3 thousand in FY25. The Average Revenue Per Occupied Bed (ARPOB) improved to Rs 67,700 from Rs 60,600.

Expansion and Management

The company continues to expand its footprint, targeting a total bed capacity of 2,900. The Dombivli hospital, with a capacity of 500 beds, was operationalised on February 25, 2026, ahead of schedule. Other projects include the Pune II (500 beds), Mira-Bhayandar (300 beds), and BKC (400 beds) facilities. Dr. Ankit Thakker, JMD & CEO, noted that FY26 was a landmark year marked by the acquisition of land at BKC and the early commissioning of the Dombivli hospital.

Jupiter Life Line Hospitals Limited has informed the stock exchanges of the resignation of Dr. Bhaskar Shah (DIN: 00007817) from the position of Non-Executive Non-Independent Director, with effect from the close of business hours on May 14, 2026. The resignation was attributed to preoccupancy and professional commitments. The initial disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and submitted to both the National Stock Exchange of India Ltd. and BSE Limited on May 15, 2026.

Updated Disclosure and Resignation Letter

In continuation of the earlier intimation dated May 15, 2026, Jupiter Life Line Hospitals filed a further disclosure on May 18, 2026, enclosing a copy of the formal resignation letter received from Dr. Bhaskar Shah. The updated filing was made in accordance with Regulation 30 read with Schedule III of the Listing Regulations and the applicable Industry Standards Note. In his resignation letter, Dr. Bhaskar Shah stated that the decision followed thoughtful consideration of his preoccupancy and professional commitments, and expressed gratitude to the Board, management team, and all stakeholders for their collaboration and support during his tenure.

Resignation Details

The key details of the change in directorship are outlined below:

Regulatory Compliance

Both the initial and updated intimations were filed by Suma Upparatti, Company Secretary and Compliance Officer of Jupiter Life Line Hospitals Limited. The company has confirmed that the relevant disclosures will be made available on its official website at www.jupiterhospital.com , affirming its adherence to disclosure obligations under the applicable listing regulations.